News

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition

News Back to resource centre 12 October 2022 Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Cambridge Cognition has entered an agreement to acquire eClinicalHealth Ltd; a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.Catalysed by the pandemic, the overall virtual clinical trials market has

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Read More »

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition

News Back to resource centre 12 October 2022 Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Cambridge Cognition has entered an agreement to acquire eClinicalHealth Ltd; a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.Catalysed by the pandemic, the overall virtual clinical trials market has

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Read More »

Cambridge Cognition selected by the University of Oxford as a cognitive assessment partner for the ISAP study

News Back to resource centre 17 August 2022 Cambridge Cognition selected by the University of Oxford as a cognitive assessment partner for the ISAP study Alzheimer’s disease validation for NeuroVocalixTMCambridge Cognition is pleased to announce that it will be collaborating with the University of Oxford by providing cognitive assessments for the Impact of Semaglutide in Amyloid Positivity (“ISAP”) study. As

Cambridge Cognition selected by the University of Oxford as a cognitive assessment partner for the ISAP study Read More »

CANTAB to be used in US Department of Defense PTSD trial

News Back to resource centre 28 July 2022 CANTAB to be used in US Department of Defense PTSD trial We are pleased to announce two agreements in a new therapeutic area for Cambridge Cognition, post-traumatic stress disorder (“PTSD”). Most recently, a research agreement was entered into with the United States Department of Defense, following on from a contract secured earlier

CANTAB to be used in US Department of Defense PTSD trial Read More »

Join us at AAIC 2022

News Back to resource centre 18 July 2022 Join us at AAIC 2022 We are looking forward to attending this year’s Alzheimer’s Association International Conference (AAIC) in San Diego from 31st July to 4th August and learning about the latest developments in dementia research.Meet us at Booth 108 to try out our tech and meet the scientists behind itCome and

Join us at AAIC 2022 Read More »

2022 CANTAB Research Grant winners announced

News Back to resource centre 14 July 2022 2022 CANTAB Research Grant winners announced It has been another highly competitive year for our CANTABTM Research Grant, with the large number of high-quality applications making picking just three winners a challenge for our judging panel! Here we reveal the winning grants.The winners each receive a CANTABTM Connect Research Licence with 150

2022 CANTAB Research Grant winners announced Read More »

Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms

News Back to resource centre 31 May 2022 Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms Cambridge Cognition is pleased to announce that they have joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measure Development project. As a partner of this innovative, collaborative effort, Cambridge Cognition will

Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms Read More »

Investigating the Impact of COVID-19 on Cognition

News Back to resource centre 13 May 2022 Investigating the Impact of COVID-19 on Cognition Children of the 90s collaborates with researchers at Cambridge Cognition to investigate the cognitive impacts of COVID-19.The Children of the 90s health study has collaborated with researchers at Cambridge Cognition, a technology company developing digital health products to assess brain health, to investigate the long-term

Investigating the Impact of COVID-19 on Cognition Read More »

Electronic Clinical Outcomes Assessment contract win worth over £500,000

News Back to resource centre 16 December 2021 Electronic Clinical Outcomes Assessment contract win worth over £500,000 Cambridge Cognition is pleased to announce that it has won a contract worth over £500,000 to provide electronic clinical outcome assessments (“eCOA”).Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has won a contract

Electronic Clinical Outcomes Assessment contract win worth over £500,000 Read More »

Cambridge Cognition wins £1.0m schizophrenia clinical trial contract

News Back to resource centre 9 December 2021 Cambridge Cognition wins £1.0m schizophrenia clinical trial contract Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has secured a contract for an additional schizophrenia clinical trial worth £1.0m.The revenue from this contract is expected over the next three years. Cambridge Cognition will

Cambridge Cognition wins £1.0m schizophrenia clinical trial contract Read More »

Scroll to Top